Hologic, Inc. (HOLX) Tops Q4 EPS by 3c; Guides
Tweet
Share
E-mailGet Alerts HOLX Hot Sheet
Price: $76.01 --0%
Financial Fact:
Research and development: 62.5M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Research and development: 62.5M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Hologic, Inc. (NASDAQ: HOLX) reported Q4 EPS of $0.37, $0.03 better than the analyst estimate of $0.34. Revenue for the quarter came in at $588.5 million versus the consensus estimate of $558.7 million.
Hologic, Inc. sees Q1 2013 EPS of $0.37, which may not compare to the consensus of $0.36. Hologic, Inc. sees Q1 2013 revenue of $640-645 million.
Hologic, Inc. sees FY2013 EPS of $1.56-1.58, which may not compare the consensus of $1.51. Hologic, Inc. sees FY2013 revenue of $2.61-2.64 billion.
For earnings history and earnings-related data on Hologic, Inc. (HOLX) click here.
Hologic, Inc. sees Q1 2013 EPS of $0.37, which may not compare to the consensus of $0.36. Hologic, Inc. sees Q1 2013 revenue of $640-645 million.
Hologic, Inc. sees FY2013 EPS of $1.56-1.58, which may not compare the consensus of $1.51. Hologic, Inc. sees FY2013 revenue of $2.61-2.64 billion.
For earnings history and earnings-related data on Hologic, Inc. (HOLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Is the global equity rally broadening? UBS weighs in
- BofA maintains underperform ratings on six BDC stocks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
